长春高新：子公司吸附无细胞百（二组分）白破联合疫苗（成人及青少年用）临床试验获批

Core Viewpoint - Changchun High-tech announced that its subsidiary, Changchun Baike Biotechnology Co., Ltd., received approval from the National Medical Products Administration for clinical trials of a combined vaccine for the prevention of whooping cough, diphtheria, and tetanus [1] Group 1 - The approval pertains to the "Adsorbed Acellular Combined Vaccine (for Adults and Adolescents)" [1] - The clinical trials are aimed at evaluating the vaccine's effectiveness in preventing three diseases: whooping cough, diphtheria, and tetanus [1]